Seroatlas · Human Serome Atlas

S100A13

Protein S100-A13

Also known as: S10AD_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q99584
Gene
S100A13
Ensembl
ENSG00000189171
Chromosome
1
Canonical length
98 aa
Protein class
Predicted intracellular proteins, Predicted secreted proteins
Subcellular location
Nucleoplasm,Nucleoli,Plasma membrane,Cytosol
Secretome location
Secreted in other tissues
Quaternary structure
Homodimer

OverviewNCBI Gene

The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21. This protein is widely expressed in various types of tissues with a high expression level in thyroid gland. In smooth muscle cells, this protein co-expresses with other family members in the nucleus and in stress fibers, suggesting diverse functions in signal transduction. Multiple alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

98 residues, UniProt reviewed canonical sequence.

>Q99584|S100A13
     1  MAAEPLTELE ESIETVVTTF FTFARQEGRK DSLSVNEFKE LVTQQLPHLL KDVGSLDEKM
    61  KSLDVNQDSE LKFNEYWRLI GELAKEIRKK KDLKIRKK

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against S100A13 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Secreted
Secreted
Yes
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.38
Highest tissue expression
415 nTPM

Expression across tissuesHPA

Tissue

  • parathyroid gland: 415 nTPM
  • choroid plexus: 303 nTPM
  • tongue: 276 nTPM
  • thyroid gland: 270 nTPM
  • heart muscle: 260 nTPM
  • breast: 252 nTPM

Single-cell type

  • hepatic stellate cells: 936 nCPM
  • esophageal apical cells: 856 nCPM
  • decidual stromal cells: 743 nCPM
  • gastric progenitor cells: 565 nCPM
  • leydig cells: 511 nCPM
  • endometrial luminal cells: 463 nCPM

Immune cell

  • NK-cell: 33 nTPM
  • plasmacytoid DC: 14 nTPM
  • myeloid DC: 8.3 nTPM
  • memory B-cell: 4.9 nTPM
  • basophil: 4.8 nTPM
  • classical monocyte: 3.2 nTPM

Brain region

  • white matter: 151 nTPM
  • thalamus: 145 nTPM
  • medulla oblongata: 135 nTPM
  • basal ganglia: 133 nTPM
  • midbrain: 127 nTPM
  • spinal cord: 124 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.67
gnomAD pLI
0.05
gnomAD missense Z
0.32
DepMap mean gene effect
0.07
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of S100A13 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads S100A13 as an antibody target. Whether an autoantibody or antibody against S100A13 could matter depends on whether native S100A13 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

S100A13 is annotated as secreted, so native S100A13 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.

Annotation status

The present source text does not explicitly label S100A13 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/S100A13. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...